In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Gregg Stone
Speaker
Gregg Stone
Gregg Stone Gregg Stone

Icahn School of Medicine at Mount Sinai, New York (United States of America)

Speciality : Interventional Cardiology

Gregg W. Stone, MD, FACC, MSCAI is is an interventional cardiologist and Director of Academic Affairs for the Mount Sinai Heart Health System and professor of Medicine (Cardiology) and Population Health Sciences and Policy, and Co-Director of Medical Research and Education at the Cardiovascular Research Foundation in New York, NY. Dr. Stone has served as the national or international principal investigator for more than 120 national and international multicenter randomized trials (many of which have led to new device approval or indications in the US), has authored more than 2000 manuscripts and abstracts published in the peer-reviewed literature, and has delivered thousands of invited lectures around the world. With a 2018 H-factor of 152, Dr. Stone was listed in Nature Medicine as one of the most prolific authors in science (2000-2016). Dr. Stone directs Transcatheter Cardiovascular Therapeutics (TCT), the world's largest symposium devoted to interventional cardiology.

18 presentations from this speaker

Discussant review - SYNTAXES

Event : ESC Congress 2019

  • Session : Hot Line Session 4
  • Speaker : G Stone (New York,US)

Mitral valve disease: to clip or not to clip?

Event : ESC Congress 2019

  • Session : The European Heart Journal’s advances in heart failure and valvular heart disease
  • Speaker : G Stone (New York,US)
  • Joint with the European Heart Journal

Reduction of mitral regurgitation in patients with heart failure and secondary mitral regurgitation: relationship between changes in brain natriuretic peptide and outcomes from the COAPT trial

Event : ESC Congress 2019

  • Session : From trials to clinical use: transcatheter interventions in secondary mitral regurgitation
  • Speaker : G Stone (New York,US)

Are DES the present and the future? New devices and platforms for PCI in stable CAD.

Event : ESC Congress 2018

  • Session : Live in the Box: PCI in stable angina - Current status and a view into the future
  • Speaker : G Stone (New York,US)

Bioresorbable vascular scaffolds - A review and outlook

Event : ESC Congress 2018

  • Session : Coronary intervention: Hot Topics in 2018
  • Speaker : G Stone (New York,US)

Left main PCI: a quick review of current data and the guidance they provide.

Event : ESC Congress 2018

  • Session : Live in the Box: left main intervention
  • Speaker : G Stone (New York,US)

Revascularisation in stable CAD is useful - Chairperson conclusion

Event : ESC Congress 2018

  • Session : Revascularisation in stable CAD: the Holy Grail or overused?
  • Speaker : G Stone (New York,US)
  • Great Debate

State of Affairs: a cautiously optimistic perspective on bioresordable scaffolds

Event : ESC Congress 2017

  • Session : Long-term outcome of coronary stents and scaffolds
  • Speaker : G Stone (New York,US)

Novel drug-filled stent designed to achieve controlled and sustained drug elution without a polymer.

Event : ESC Congress 2016

  • Session : The future is in the pipeline
  • Speaker : G Stone (New York,US)

Primary endpoint is positive, is that enough? A clinical perspective.

Event : ESC Congress 2016

  • Session : Interpreting clinical trials: does a primary endpoint tell it all?
  • Speaker : G Stone (New York,US)

Update on clinical data after bioresorbable vascular device implantation

Event : ESC Congress 2016

  • Session : Bioresorbable vascular scaffold
  • Speaker : G Stone (New York,US)

ABSORB STEMI TROFI II: Discussant review.

Event : ESC Congress 2015

  • Session : Hot Line VI - Coronary artery disease
  • Speaker : G Stone (New York,US)

Peri-infarct zone pacing to prevent adverse left ventricular remodeling in patients with very large myocardial infarction

Event : ESC Congress 2015

  • Session : Hot Line I - Acute myocardial infarction
  • Speaker : G Stone (New York,US)

Implications of invasive detection of plaque vulnerability.

Event : ESC Congress 2014

  • Session : Assessment of coronary atherosclerosis and plaque vulnerability to guide treatment
  • Speaker : G Stone (New York,US)

Is thrombus aspiration needed in primary PCI?

Event : ESC Congress 2014

  • Session : Challenges in antithrombotic treatment of STEMI
  • Speaker : G Stone (New York,US)

SYNTAX/EXCEL.

Event : ESC Congress 2014

  • Session : Strategy trials: important or impossible?
  • Speaker : G Stone (New York,US)

Intracoronary pharmacotherapy.

Event : ESC Congress 2013

  • Session : Novel adjunctive therapies in primary percutaneous coronary intervention
  • Speaker : G Stone (New York,US)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are